The company said late on Wednesday that it had sold a 2% stake, or 26.5 million ordinary shares, through a private placement. As a result, Siemens' stake in Healthineers has decreased from 75% to 73%.
According to a Reuters report, CEO Roland Busch has said that Siemens would likely reduce its stake in Healthineers by around 5% this year, and also offload 6% of its holding in Siemens Energy.
Strong investor appetite allowed Siemens to increase the transaction size from 22 million shares initially. The company said proceeds will be used for "general corporate purposes."
A Siemens spokesperson said the company had previously communicated that proceeds would help to finance the acquisition of Altair Engineering.
Last year's $10.6 billion acquisition of Altair was the second biggest in the company's history.
"This intention has not changed," the spokesperson said.
Siemens has agreed to a lockup period where it will not sell more of its remaining 823.5 million shares for 90 calendar days.
Shares in Siemens Healthineers fell in early trading.
Morgan Stanley, Barclays, and BNP Paribas acted as global coordinators and book runners for the sale, which will be completed on February 24.
Siemens also recently reduced its holding in Siemens Energy from 15% to 14.3%, and has said it will gradually reduce this further during 2025.
The company intends to provide a strategic update on Siemens Healthineers to investors in December this year, CFO Ralf Thomas told analysts last week.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.